By
AmyT on
March 27, 2013
Santa Clara, California, is a very sunny place, even in March. But I didn’t mind so much spending the whole of last Saturday indoors at the convention center there since TCOYD conferences are always super-informative with a fun, casual vibe.
I was privileged to be taking part in the new Type 1 Track, in a session about the Diabetes Online Community, moderated by Kelly Close of diaTribe, and including other DOC celebs Kerri Sparling of…
Read more »
The biggest thing in diabetes headlines of late is Bydureon, the first and only once-a-week drug to help type 2 diabetics keep their sugars in check, which is newly approved by the FDA. Amylin’s stock price is up, and the pharma blogosphere is all abuzz. But if you’re like us, you may be wondering what the really big deal is. New type 2 drugs come out all the time, don’t they?
Well, for one thing,…
Read more »
By
AmyT on
December 11, 2008
There are a lot of things going on at the troubled Food and Drug Administration right now that could have a profound impact on the future of diabetes care, but most of us patients never hear about them. And that’s a damn shame. Because we stand at a crossroads.
You may or may not be aware that the Obama Administration is about to appoint a new FDA Commissioner. The politics and personal leanings of this…
Read more »
